Ras enhances Myc protein stability
- PMID: 10078200
- DOI: 10.1016/s1097-2765(00)80308-1
Ras enhances Myc protein stability
Abstract
Various experiments have demonstrated a collaborative action of Myc and Ras, both in normal cell growth control as well as during oncogenesis. We now show that Ras enhances the accumulation of Myc activity by stabilizing the Myc protein. Whereas Myc has a very short half-life when produced in the absence of mitogenic signals, due to degradation by the 26S proteasome, the half-life of Myc increases markedly in growth-stimulated cells. This stabilization is dependent on the Ras/Raf/MAPK pathway and is not augmented by proteasome inhibition, suggesting that Ras inhibits the proteasome-dependent degradation of Myc. We propose that one aspect of Myc-Ras collaboration is an ability of Ras to enhance the accumulation of transcriptionally active Myc protein.
Similar articles
-
VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells.Oncogene. 1999 Apr 1;18(13):2221-30. doi: 10.1038/sj.onc.1202527. Oncogene. 1999. PMID: 10327068
-
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.Genes Dev. 2000 Oct 1;14(19):2501-14. doi: 10.1101/gad.836800. Genes Dev. 2000. PMID: 11018017 Free PMC article.
-
Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy.Eur J Immunol. 2002 Sep;32(9):2500-9. doi: 10.1002/1521-4141(200209)32:9<2500::AID-IMMU2500>3.0.CO;2-S. Eur J Immunol. 2002. PMID: 12207334
-
Ras target proteins in eukaryotic cells.FASEB J. 1995 Oct;9(13):1311-8. doi: 10.1096/fasebj.9.13.7557021. FASEB J. 1995. PMID: 7557021 Review.
-
The 3Rs of life: Ras, Raf and growth regulation.Trends Genet. 1994 Feb;10(2):44-8. doi: 10.1016/0168-9525(94)90147-3. Trends Genet. 1994. PMID: 8191584 Review.
Cited by
-
KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development.bioRxiv [Preprint]. 2024 May 23:2023.07.01.547283. doi: 10.1101/2023.07.01.547283. bioRxiv. 2024. PMID: 38826439 Free PMC article. Preprint.
-
Combinatorial strategies to target RAS-driven cancers.Nat Rev Cancer. 2024 May;24(5):316-337. doi: 10.1038/s41568-024-00679-6. Epub 2024 Apr 16. Nat Rev Cancer. 2024. PMID: 38627557 Review.
-
Manipulating Myc for reparative regeneration.Front Cell Dev Biol. 2024 Mar 21;12:1357589. doi: 10.3389/fcell.2024.1357589. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38577503 Free PMC article. Review.
-
LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m6 A modification in triple-negative breast cancer.Clin Transl Med. 2024 Feb;14(2):e1583. doi: 10.1002/ctm2.1583. Clin Transl Med. 2024. PMID: 38372449 Free PMC article.
-
Overexpression of deubiquitinase (usp 36) in oral squamous cell carcinoma.J Oral Maxillofac Pathol. 2023 Oct-Dec;27(4):623-628. doi: 10.4103/jomfp.jomfp_311_23. Epub 2023 Dec 20. J Oral Maxillofac Pathol. 2023. PMID: 38304515 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous